[ Follow Us On Twitter ]    #Stocks    #TSX    #TSXV    #CNQ    #NASDAQ    @MarketTrendNews
June 16th - Gold Producer - Watchlist Update
Dear Valued Readers,

I'd like to welcome all our new subscribers!

Our sponsor released very positive news! Enter the Amazon Draw and get more information before more news hits the wire!

Today the US Fed decided not to raise interest rates. This weakens the US $ which is good for Gold. Gold is pushing $1300US/oz again. Should go higher.
People were speculating there would be  a rate increase at this meeting but the Non-Farm payroll numbers for June were brutal and the June 23rd Great Britain referendum on leaving the European Union is putting uncertainty in the markets.

With Gold going up I revisit a company I have been following since it was called Quicksilver at $1. I reviewed it on Oct. 20th, 2014 and it was at $2.13CA. Symbol AKG on the TSX. Trades on the NYSE MKT as AKG also. Asanko set a 52 week high today and closed at $5.42CA. More info below.

Two weeks ago we gave an update on a stock I own called Auryn Resources AUG-TSXV at $2.35CA per share. The freight train continues to roll and set new all time highs of $2.83CA today, closing at $2.78 up .18. The company announced yesterday that they are acquiring Homestake Resources for $8.9M in an all share deal.
PLATINUM members get all the info and the new research note on Auryn that I got. Just fill out the form for our sponsor, which will also get you in the Amazon Draw!

What do you think will happen if Trump gets in? With respect to the markets?
I have a podcast you should listen to. Everyone who responds will get the link to it.

You are NOT on the Platinum list unless you see Platinum under the year 2016 in the header. Platinum members get the newsletter first.   Subscribe to Platinum with a Deliverable Address

Remember, I'm an investor/trader like you. This is not investment advice, these are my opinions. Please consult your advisor before buyin or selling anything.

Thank You!


Our Featured Sponsor:

27.8 Million Shares and closed yesterday at 7.5 cents.

Our featured company is the developer of wireless monitoring technology for electrical utilities and other infrastructure entities.

June 14th Announcement: Testing Agreements with.....

May 19th Announcement: The company has successfully tested its sensor and anti-corona ring on high voltage at one of Canada's major Power company's hydro test facility. The sensor and the anti-corona ring passed the test with 20-per-cent margin.

"We are very excited with this milestone as we prepare our dynamic power-line-rating sensor technology for field deployment," said the president of the company.

Pilot negotiations underway with utilities in North America and Europe.

The company has 5 patents and over $10 million of investment in technology to date.

Get more information on this company before more news comes out!


The Platinum Newsletter List:

[ Subscribe to Platinum
with a Deliverable Address


Asanko Gold

Asanko Gold was actually started by some of the people involved in Auryn Resources. These people are company builders!

They went into West Africa, acquired amazing properties, and proved up a mine. Usually these companies get bought out, but oh no, they built the mine too!

In early 2016 they started production and the stock chart is moving on up!

About Asanko Gold Inc.

Asanko's vision is to become a mid-tier gold mining company that maximizes value for all its stakeholders. The Company's flagship project is the multi-million ounce Asanko Gold Mine located in Ghana, West Africa. The mine is being developed in phases. Phase 1 was built within budget and ahead of schedule, with gold production commencing in January 2016 and commercial production declared on April 1, 2016. Ramp-up to steady-state production of 190,000 ounces per annum is expected in Q2 2016.

Asanko is managed by highly skilled and successful technical, operational and financial professionals. The Company is strongly committed to the highest standards for environmental management, social responsibility, and health and safety for its employees and neighbouring communities.

So much information at their web site.


People who respond will be entered into our draw to be drawn when we have 100 entries!
More Sponsor Information:
People who respond get a 13 page corporate PDF presentation and access to their very informative web site.
Enter Draw / More Information
Yesterday's Movers

Aegerion Pharmaceuticals and QLT Inc. Agree to Strategic Merger
Nasdaq:AEGR +34%

--Strategic Merger Creates Well-Capitalized, Global Biopharmaceutical Organization with Diverse Portfolio of Two Commercialized Rare Disease Programs and a Phase 3 Ready Ultra-Orphan Development Program Addressing Significant Unmet Medical Need--

--Broad-Based Investor Syndicate to Vote in Favor of the Merger and Provide Concurrent Financing of Approximately $22 Million--

--Companies to Host Conference Call Today at 8:30 a.m. ET-- CAMBRIDGE, Mass. and VANCOUVER, British Columbia, June 15, 2016 --

Aegerion Pharmaceuticals, Inc. (AEGR) (“Aegerion”) and QLT Inc. (QLTI) (QLT.TO) (“QLT”) today announced that they have entered into a definitive merger agreement under which Aegerion will be merged with a wholly owned indirect subsidiary of QLT.

Read More

Cellectar Biosciences Announces Results of In Vivo Study Demonstrating PDC Platform Delivery of Paclitaxel to be Superior in Tumor Targeting to Free Paclitaxel

CLR 1602 Tumor Selectivity Shown to be Approximately 30 Times Greater than Paclitaxel Alone

MADISON, Wis., June 15, 2016 -- Cellectar Biosciences, Inc. (CLRB) ("the company"), an oncology-focused biotechnology company, today announces the results of a preliminary tumor-targeting study that shows its prototype paclitaxel chemotherapeutic conjugate, CLR 1602, may be up to 30 times more tumor selective in comparison to free paclitaxel.

The preliminary in vivo study demonstrated that tumor uptake of CLR 1602’s paclitaxel payload increased by more than 30-fold over free paclitaxel, and also displayed an extended plasma half-life relative to free paclitaxel. The extended plasma half-life may, in part, explain the enhanced tumor uptake. Unlike free paclitaxel, which was rapidly cleared from plasma within 24 hours, CLR 1602 displayed prolonged retention even at 96 hours.

Read More

MGT Appoints the Executive Director of the Bitcoin Foundation to its Cryptocurrency Advisory Board
AMEX: MGT +27%

HARRISON, N.Y., June 15, 2016 -- MGT Capital Investments, Inc. (NYSE MKT: MGT) today announced the appointment of Bruce Fenton to its Cryptocurrency Advisory Board, effective immediately.

Fenton is currently the Executive Director of the Bitcoin Foundation, and founder and CEO of Atlantic Financial. He is a leading economic strategist and advisor with a focus on the changing global economy. Fenton is a specialist in emerging technology such as digital currency and emerging markets. Fenton also advises U.S. and global investment clients and provides consulting and project based services to banks, financial organizations, charitable organizations and families. He has worked with a major leading U.S. based private equity and investment firm, one of the world's largest global charities and several other families and foundations. Fenton has placed over $5 billion in investment capital with money managers and funds during his career. Early in his career, Fenton worked for Morgan Stanley Dean Witter (formerly Dean Witter) starting in 1992. At Morgan Stanley Dean Witter, he was a specialist in managed accounts and one of the youngest stockbrokers ever to work for the company.

Read More



If your not interested in stocks or other financial commentaries then please use our instantaneous removal link in the footer of the newsletter.


READ This Too

Please be advised that YOU are responsible for your own actions and you should consult your investment advisor before making any investment decisions.


Our sponsoring company has paid for an advertising package with Market Trend News Inc. Market Trend News Inc has no stock position in the company being featured. Winner of the draw must reside in North America.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -